466 related articles for article (PubMed ID: 15168373)
1. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases.
Itzkowitz SH; Harpaz N
Gastroenterology; 2004 May; 126(6):1634-48. PubMed ID: 15168373
[TBL] [Abstract][Full Text] [Related]
2. Outcome of "indefinite for dysplasia" in inflammatory bowel disease: correlation with DNA flow cytometry and other risk factors of colorectal cancer.
Choi WT; Rabinovitch PS; Wang D; Westerhoff M
Hum Pathol; 2015 Jul; 46(7):939-47. PubMed ID: 25962315
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic problems and advances in inflammatory bowel disease.
Odze R
Mod Pathol; 2003 Apr; 16(4):347-58. PubMed ID: 12692200
[TBL] [Abstract][Full Text] [Related]
4. Dysplasia in inflammatory bowel disease.
Greenson JK
Semin Diagn Pathol; 2002 Feb; 19(1):31-7. PubMed ID: 11936264
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory bowel disease in Ashkenazi Jews: implications for familial colorectal cancer.
Lynch HT; Brand RE; Locker GY
Fam Cancer; 2004; 3(3-4):229-32. PubMed ID: 15516846
[TBL] [Abstract][Full Text] [Related]
6. Chronic inflammatory bowel disease and cancer.
Pohl C; Hombach A; Kruis W
Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
[TBL] [Abstract][Full Text] [Related]
7. Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study.
Lindberg BU; Broomé U; Persson B
Dis Colon Rectum; 2001 Jan; 44(1):77-85. PubMed ID: 11805567
[TBL] [Abstract][Full Text] [Related]
8. Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy?
Moussata D; Allez M; Cazals-Hatem D; Treton X; Laharie D; Reimund JM; Bertheau P; Bourreille A; Lavergne-Slove A; Brixi H; Branche J; Gornet JM; Stefanescu C; Moreau J; Marteau P; Pelletier AL; Carbonnel F; Seksik P; Simon M; Fléjou JF; Colombel JF; Charlois AL; Roblin X; Nancey S; Bouhnik Y; Berger F; Flourié B;
Gut; 2018 Apr; 67(4):616-624. PubMed ID: 28115492
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory bowel disease as a risk factor for colorectal cancer.
Lukas M
Dig Dis; 2010; 28(4-5):619-24. PubMed ID: 21088413
[TBL] [Abstract][Full Text] [Related]
10. Toward a consensus on endoscopic surveillance of patients with colonic inflammatory bowel disease.
Shergill AK; Farraye FA
Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):469-81. PubMed ID: 24975537
[TBL] [Abstract][Full Text] [Related]
11. High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease.
Shah SC; Ten Hove JR; Castaneda D; Palmela C; Mooiweer E; Colombel JF; Harpaz N; Ullman TA; van Bodegraven AA; Jansen JM; Mahmmod N; van der Meulen-de Jong AE; Ponsioen CY; van der Woude CJ; Oldenburg B; Itzkowitz SH; Torres J
Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1106-1113.e3. PubMed ID: 29378311
[TBL] [Abstract][Full Text] [Related]
12. Paradigm Shift in the Surveillance and Management of Dysplasia in Inflammatory Bowel Disease (West).
Soetikno R; Kaltenbach T; McQuaid KR; Subramanian V; Kumar R; Barkun AN; Laine L
Dig Endosc; 2016 Apr; 28(3):266-73. PubMed ID: 26866420
[TBL] [Abstract][Full Text] [Related]
13. [Pathobiology of dysplasia in chronic inflammatory bowel disease: Current recommendations for surveillance of dysplasia].
Raithel M; Weidenhiller M; Schwab D; Müller S; Hahn EG
Z Gastroenterol; 2001 Oct; 39(10):861-75. PubMed ID: 11605156
[TBL] [Abstract][Full Text] [Related]
14. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
Rubin DT; Rothe JA; Hetzel JT; Cohen RD; Hanauer SB
Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704
[TBL] [Abstract][Full Text] [Related]
15. Surveillance for dysplasia in patients with inflammatory bowel disease: a national survey of colonoscopic practice in New Zealand.
Gearry RB; Wakeman CJ; Barclay ML; Chapman BA; Collett JA; Burt MJ; Frizelle FA
Dis Colon Rectum; 2004 Mar; 47(3):314-22. PubMed ID: 14991493
[TBL] [Abstract][Full Text] [Related]
16. Dysplasia and Cancer in Inflammatory Bowel Disease.
Huang LC; Merchea A
Surg Clin North Am; 2017 Jun; 97(3):627-639. PubMed ID: 28501251
[TBL] [Abstract][Full Text] [Related]
17. Low-grade dysplasia in extensive, long-standing inflammatory bowel disease: a follow-up study.
Befrits R; Ljung T; Jaramillo E; Rubio C
Dis Colon Rectum; 2002 May; 45(5):615-20. PubMed ID: 12004210
[TBL] [Abstract][Full Text] [Related]
18. High Adherence to Surveillance Guidelines in Inflammatory Bowel Disease Patients Results in Low Colorectal Cancer and Dysplasia Rates, While Rates of Dysplasia are Low Before the Suggested Onset of Surveillance.
Singh K; Al Khoury A; Kurti Z; Gonczi L; Reinglas J; Verdon C; Kohen R; Bessissow T; Afif W; Wild G; Seidman E; Bitton A; Lakatos PL
J Crohns Colitis; 2019 Sep; 13(10):1343-1350. PubMed ID: 30918959
[TBL] [Abstract][Full Text] [Related]
19. Real-life chromoendoscopy for neoplasia detection and characterisation in long-standing IBD.
Carballal S; Maisterra S; López-Serrano A; Gimeno-García AZ; Vera MI; Marín-Garbriel JC; Díaz-Tasende J; Márquez L; Álvarez MA; Hernández L; De Castro L; Gordillo J; Puig I; Vega P; Bustamante-Balén M; Acevedo J; Peñas B; López-Cerón M; Ricart E; Cuatrecasas M; Jimeno M; Pellisé M;
Gut; 2018 Jan; 67(1):70-78. PubMed ID: 27612488
[TBL] [Abstract][Full Text] [Related]
20. Clinical implications of low grade dysplasia found during inflammatory bowel disease surveillance: a retrospective study comparing chromoendoscopy and white-light endoscopy.
Ten Hove JR; Mooiweer E; van der Meulen de Jong AE; Dekker E; Ponsioen CY; Siersema PD; Oldenburg B
Endoscopy; 2017 Feb; 49(2):161-168. PubMed ID: 27951611
[No Abstract] [Full Text] [Related]
[Next] [New Search]
